Table 3

Prevalence of different STI in Tunisian FSW

TotalNew FSW (<5 years)Old FSW (≥5 years)OR (95% CI)p Value
N=188 (%)N=63 (%)N=125 (%)
Any STI marker detected186 (98.9)63 (100)123 (98.4)0.31
Any current STI163 (86.7)58 (92.1)105 (84)0.45 (0.16 to 1.26)0.12
One STI detected70 (37.2)22 (34.9)48 (38.4)1.16 (0.61 to 2.18)0.64
Two or more STI detected93 (49.5)36 (57.1)57 (45.6)0.62 (0.34 to 1.15)0.13
N gonorrhoeae21 (11.2)11 (17.5)10 (8)2.43 (0.89 to 6.67)0.05
C trachomatis
C trachomatis-positive PCR137 (72.9)48 (76.2)89 (71.2)0.77 (0.38 to 1.55)0.46
C trachomatis-positive serology157/183 (85.8)51/63 (81)106/120 (88.3)1.7 (0.76 to 3.87)0.17
C trachomatis-positive serology with high titres (≥128)103/183 (56.3)28/63 (44.4)75/120 (62.5)2.08 (1.21 to 3.87)0.02
Syphilis5/183 (2.7)05/120 (4.2)0.64 (0.58 to 0.72)0.1
HCV2/183 (1.1)1/63 (0.8)1/120 (1.6)1.91 (0.11 to 31.21)0.64
Hepatitis B
 Hbs antigen1/183 (0.5)01/120 (0.8)0.65 (0.58 to 0.72)0.46
 Hepatitis B core IgG59/183 (31.4)7/63 (11.3)52/120 (43.3)6 (2.52 to 14.27)<0.001
HSV-2
 HSV-2 serology105/183 (55.5)30/63 (47.6)71/120 (59.7)1.62 (0.37 to 3.01)0.12
 HSV-2 PCR2 (1.1)2 (3.2)00.11
HPV83 (44.1)32 (50.8)51 (40.8)0.16 (0.36 to 1.22)0.19
HIV0 (0)00
  • FSW, female sex worker; HPV, human papillomavirus; HSV-2, herpes simplex virus type 2; STI, sexually transmitted infection.